D. Milliner

发表

The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein

Vicente E. Torres, Dawn S. Milliner, Peter C. Harris, 2002, Nature Genetics.

Erratum: The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II (Human Molecular Genetics (1999) 8 (2063-2069))

S. Cramer, D. Milliner, K. Lin, 1999 .

The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II.

S. Cramer, D. Milliner, K. Lin, 1999, Human molecular genetics.

Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement

J. Lingeman, G. Capasso, G. Gambaro, 2016, Journal of Nephrology.

Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II.

D. Milliner, G. Rumsby, C. Monico, 2002, Kidney international.

Neonatal presentation of autosomal dominant polycystic kidney disease with a maternal history of tuberous sclerosis.

V. Torres, P. Harris, D. Milliner, 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery.

A. Rule, J. Lieske, M. Collazo-Clavell, 2007, Kidney international.

Mutations in DHDPSL are responsible for primary hyperoxaluria type III.

C. Charon, D. Magen, R. Belostotsky, 2010, American journal of human genetics.

Genetic Risk Factors for Idiopathic Urolithiasis: A Systematic Review of the Literature and Causal Network Analysis.

B. Hoppe, D. Milliner, T. Yasui, 2017, European urology focus.

Oxalosis Associated With High-Dose Vitamin C Ingestion in a Peritoneal Dialysis Patient.

J. Lieske, D. Milliner, L. Hickson, 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Clinical characterization of primary hyperoxaluria type 3 in comparison to types 1 and 2: a retrospective cohort study.

J. Lieske, P. Harris, D. Milliner, 2021, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the National Kidney Foundation conference on proteinuria, albuminuria, risk, assessment, detection, and elimination (PARADE).

J. Ingelfinger, R. Portman, D. Milliner, 2000, Pediatrics.

Effect of cyclosporine A on long-term allograft function in pediatric renal transplant recipients

B. Morgenstern, D. Milliner, A. Williams, 1994, Pediatric Nephrology.

Urolithiasis in pediatric patients.

D. Milliner, M. E. Murphy, 1993, Mayo Clinic proceedings.

Specific populations of urinary extracellular vesicles and proteins differentiate type 1 primary hyperoxaluria patients without and with nephrocalcinosis or kidney stones

A. Rule, J. Lieske, N. Larson, 2020, Orphanet Journal of Rare Diseases.

Prognosis of patients with unilateral renal agenesis

E. Bergstralh, D. Milliner, M. Ritchey, 1992, Pediatric Nephrology.

Prognosis of children with solitary kidney after unilateral nephrectomy.

E. Bergstralh, D. Milliner, M. Ritchey, 1992, The Journal of urology.

A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria

B. Hoppe, D. Milliner, J. Groothoff, 2017, Urolithiasis.

Knowledge management in the era of digital medicine: A programmatic approach to optimize patient care in an academic medical center

Jane L. Shellum, J. Noseworthy, R. Nishimura, 2017, Learning health systems.

The Primary Hyperoxalurias: Molecular and Clinical Insights

D. Milliner, G. Rumsby, C. Monico, 2008 .

Genetic determinants of urolithiasis

D. Milliner, C. Monico, 2012, Nature Reviews Nephrology.

Extraction of glyceric and glycolic acids from urine with tetrahydrofuran: utility in detection of primary hyperoxaluria.

D. Milliner, D. Dietzen, M. Landt, 1997, Clinical chemistry.

Temporal trends in incidence of kidney stones among children: a 25-year population based study.

A. Rule, J. Lieske, E. Bergstralh, 2012, The Journal of urology.

Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.

D. Stablein, D. Milliner, G. Ciancio, 2004, Journal of the American Society of Nephrology : JASN.

Pulmonary calcinosis after renal transplantation in pediatric patients.

D. Milliner, E. Lieberman, B. Landing, 1986, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Kidney stones are common after bariatric surgery

A. Rule, J. Lieske, E. Bergstralh, 2014, Kidney international.

Urolithiasis and Nephrocalcinosis in Childhood

B. Hoppe, D. Milliner, E. Leumann, 2008 .

Urinary Oxalate Excretion Increases in Home Parenteral Nutrition Patients on a Higher Intravenous Ascorbic Acid Dose.

J. Lieske, D. Milliner, D. Kelly, 2004, JPEN. Journal of parenteral and enteral nutrition.

Pathophysiology and Treatment of Enteric Hyperoxaluria.

D. Assimos, J. Lieske, D. Milliner, 2020, Clinical journal of the American Society of Nephrology : CJASN.

Endpoints for Clinical Trials in Primary Hyperoxaluria.

W. Lowther, J. Lieske, A. Thompson, 2020, Clinical journal of the American Society of Nephrology : CJASN.

Phenotypic and functional analysis of human SLC26A6 variants in patients with familial hyperoxaluria and calcium oxalate nephrolithiasis.

E. Bergstralh, D. Milliner, P. Aronson, 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Cardiac abnormalities in primary hyperoxaluria.

J. Lieske, D. Milliner, P. Jiamsripong, 2010, Circulation Journal.

Plasma aluminum levels in pediatric dialysis patients: comparison of hemodialysis and continuous ambulatory peritoneal dialysis.

D. Milliner, J. Coburn, E. Lieberman, 1987, Mayo Clinic proceedings.

Genetic Causes of Kidney Stones and Kidney Failure

J. Lieske, D. Goldfarb, D. Milliner, 2012, Clinical Reviews in Bone and Mineral Metabolism.

Renal transplantation in Alport's syndrome: anti-glomerular basement membrane glomerulonephritis in the allograft.

A. Pierides, K. E. Holley, D. Milliner, 1982, Mayo Clinic proceedings.

Postdilution hemofiltration in the management of acute hepatic failure: a pilot study.

D. Milliner, J. Rakela, J. McCarthy, 1988, Mayo Clinic proceedings.

Posttransplant recurrence of calcium oxalate crystals in patients with primary hyperoxaluria: Incidence, risk factors, and effect on renal allograft function

M. Stegall, J. Lieske, J. Heimbach, 2021, American Journal of Transplantation.

Two cases of non-O157:H7 Escherichia coli hemolytic uremic syndrome caused by urinary tract infection.

M. Hogan, D. Milliner, F. Cockerill, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Decreased Incidence of Acute Rejection in Adolescent Kidney Transplant Recipients Using Antithymocyte Induction and Triple Immunosuppression

M. Stegall, B. Morgenstern, D. Milliner, 2007, Transplantation.

Soft tissue calcification in pediatric patients with end-stage renal disease.

A. Zinsmeister, D. Milliner, E. Lieberman, 1990 .

Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria

E. Bergstralh, D. Milliner, Lynwood H. Smith, 1994, Pediatric Nephrology.

Soft tissue calcification in pediatric patients with end-stage renal disease

A. Zinsmeister, D. Milliner, E. Lieberman, 1991, Pediatric Nephrology.

Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass.

J. Lieske, D. Milliner, M. Sarr, 2005, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

Glyoxylate reductase activity in blood mononuclear cells and the diagnosis of primary hyperoxaluria type 2.

S. Cramer, D. Milliner, R. Holmes, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Clinical and molecular characterization of primary hyperoxaluria in Egypt

P. Harris, D. Milliner, A. Cogal, 2022, Scientific Reports.

A test of the hypothesis that oxalate secretion produces proximal tubule crystallization in primary hyperoxaluria type I.

J. Lingeman, A. Evan, D. Milliner, 2013, American journal of physiology. Renal physiology.

Ureteropelvic junction obstruction with concurrent renal pelvic calculi in the pediatric patient: a long-term followup.

D. Milliner, J. W. Segura, D. Husmann, 1996, The Journal of urology.

URETEROPELVIC JUNCTION OBSTRUCTION WITH CONCURRENT FOLLOWUP RENAL PELVIC CALCULI IN THE PEDIATRIC PATIENT: A LONG-TERM

D. Milliner, J. W. Segura, D. A. Husma, 1996 .

Ureteropelvic junction obstruction with a simultaneous renal calculus: long-term followup.

D. Milliner, J. W. Segura, D. Husmann, 1995, The Journal of urology.

Sonographically Guided Percutaneous Radio Frequency Ablation of a Renal Cell Carcinoma in a Transplanted Kidney

J. Charboneau, D. Milliner, D. Engen, 2002, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Role of Aluminum Accumulation in Renal Osteodystrophy

S. Ott, D. Milliner, J. Coburn, 1984 .

4-Hydroxy-2-oxoglutarate aldolase inactivity in primary hyperoxaluria type 3 and glyoxylate reductase inhibition.

W. Lowther, D. Milliner, R. Holmes, 2012, Biochimica et biophysica acta.

Indirect methods for the diagnosis of aluminum bone disease: plasma aluminum, the desferrioxamine infusion test, and serum iPTH.

S. Ott, D. Milliner, D. Sherrard, 1986, Kidney international. Supplement.

Use of the deferoxamine infusion test in the diagnosis of aluminum-related osteodystrophy.

S. Ott, D. Milliner, D. Sherrard, 1984, Annals of internal medicine.

End Points for Clinical Trials in Hyperoxaluria: Case Study of Patient-Focused Drug Development in a Rare Disease.

J. Lieske, D. Milliner, Melissa West, 2021, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Kidney Transplantation for Primary Focal Segmental Glomerulosclerosis: Outcomes and Response to Therapy for Recurrence

T. Larson, M. Stegall, F. Cosio, 2009, Transplantation.

Lipid levels following renal transplantation in pediatric recipients.

B. Morgenstern, D. Milliner, S. Sterioff, 1994, Transplantation proceedings.

Changes in bone histology after treatment with desferrioxamine.

S. Ott, D. Milliner, D. Sherrard, 1986, Kidney international. Supplement.

Nephrocalcinosis is a risk factor for kidney failure in primary hyperoxaluria

T. Vrtiska, J. Lieske, E. Bergstralh, 2014, Kidney international.

Clinical and laboratory features of aluminum-related bone disease: differences between sporadic and "epidemic" forms of the syndrome.

Keith C. Norris, D. Milliner, D. Sherrard, 1985, American journal of kidney diseases : the official journal of the National Kidney Foundation.

siRNA Therapeutics for Primary Hyperoxaluria: A Beginning.

D. Milliner, 2016, Molecular Therapy.

The primary hyperoxalurias.

B. Hoppe, D. Milliner, B. Beck, 2009, Kidney international.

Update on Oxalate Crystal Disease

J. Lieske, C. Michet, D. Milliner, 2013, Current Rheumatology Reports.

Chronic renal failure secondary to oxalate nephropathy: a preventable complication after jejunoileal bypass.

L. Juncos, D. Milliner, M. Sarr, 2001, Mayo Clinic proceedings.

Phenotypic expression of primary hyperoxaluria: comparative features of types I and II.

D. Milliner, L. Smith, D. Wilson, 2001, Kidney international.

Long-term prognosis in primary hyperoxaluria type II (L-glyceric aciduria).

D. Milliner, L. Smith, P. T. Chlebeck, 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria.

Pierre Cochat, Bernd Hoppe, B. Hoppe, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Urinary oxalate and glycolate excretion patterns in the first year of life: a longitudinal study.

B. Morgenstern, T. Moyer, D. Milliner, 1993, The Journal of pediatrics.

Treatment of the primary hyperoxalurias: a new chapter.

D. Milliner, 2006, Kidney international.

Plasma oxalate and eGFR are correlated in primary hyperoxaluria patients with maintained kidney function—data from three placebo-controlled studies

D. Milliner, S. Hulton, P. Cochat, 2021, Pediatric Nephrology.

Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy.

Dawn S Milliner, Rajiv Kumar, R. Kumar, 2012, The Journal of clinical endocrinology and metabolism.

Plasma oxalate in relation to eGFR in patients with primary hyperoxaluria, enteric hyperoxaluria and urinary stone disease.

J. Lieske, D. Milliner, F. Enders, 2017, Clinical biochemistry.

Assessment of Urine Proteomics in Type 1 Primary Hyperoxaluria

E. Salido, B. Hoppe, D. Milliner, 2016, American Journal of Nephrology.

Surgical management of stone disease in patients with primary hyperoxaluria.

M. Gettman, D. Milliner, A. Krambeck, 2015, Urology.

Hereditary causes of kidney stones and chronic kidney disease

Dawn S. Milliner, John C. Lieske, Franca Anglani, 2013, Pediatric Nephrology.

Transplantation Outcomes in Primary Hyperoxaluria

E. Bergstralh, J. Lieske, E. Bergstralh, 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

International Registry for Primary Hyperoxaluria

E. Bergstralh, J. Lieske, D. Milliner, 2005, American Journal of Nephrology.

The Primary Hyperoxalurias: An Algorithm for Diagnosis

D. Milliner, 2005, American Journal of Nephrology.

Hyperoxaluria and urolithiasis in young children: an atypical presentation.

D. Milliner, C. Monico, 1999, Journal of endourology.

Predictors of Incident ESRD among Patients with Primary Hyperoxaluria Presenting Prior to Kidney Failure.

Lisa E. Vaughan, J. Lieske, E. Bergstralh, 2016, Clinical journal of the American Society of Nephrology : CJASN.

Primary Hyperoxaluria Type 3 Can Also Result in Kidney Failure: A Case Report.

J. Lieske, P. Harris, D. Milliner, 2021, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Recent advances in the identification and management of inherited hyperoxalurias

P. Harris, D. Milliner, David J. Sas, 2018, Urolithiasis.

Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1

P. Haslett, J. Lieske, D. Magen, 2021, Clinical journal of the American Society of Nephrology : CJASN.

Primary Hyperoxaluria: Long-Term Outcome in Patients Treated with Orthophosphate and Pyridoxine

D. Milliner, L. Smith, 1994 .

Crystalline nephropathy due to 2,8-dihydroxyadeninuria: an under-recognized cause of irreversible renal failure.

D. Milliner, S. Nasr, L. Cornell, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Clinical experience with desferrioxamine in dialysis patients with aluminium toxicity.

W. J. Johnson, D. Milliner, J. McCarthy, 1990, The Quarterly journal of medicine.

Clearance of aluminum by hemodialysis: effect of desferrioxamine.

A. Nissenson, D. Milliner, J. Coburn, 1986, Kidney international. Supplement.

Urinary tract anomalies detected by prenatal ultrasound examination at Mayo Clinic Rochester.

B. Morgenstern, D. Milliner, P. Ogburn, 1995, Mayo Clinic proceedings.

Triamterene crystalline nephropathy.

D. Milliner, S. Nasr, S. Sethi, 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Oxalate Quantification in Hemodialysate to Assess Dialysis Adequacy for Primary Hyperoxaluria

J. Lieske, D. Milliner, J. Olson, 2014, American Journal of Nephrology.

Acute interstitial nephritis: immunologic and clinical aspects.

V. Torres, K. E. Holley, D. Milliner, 1988, Mayo Clinic proceedings.

Renal Artery Intervention in Pediatric and Adolescent Patients: A 20-Year Experience

M. Mckusick, D. Milliner, T. Hoskin, 2008, Vascular and endovascular surgery.

Comprehensive Genetic Analysis Reveals Complexity of Monogenic Urinary Stone Disease

J. Lieske, D. Goldfarb, P. Harris, 2021, Kidney international reports.

Urinary monocyte chemoattractant protein 1 associated with calcium oxalate crystallization in patients with primary hyperoxaluria

Lisa E. Vaughan, D. Assimos, J. Lieske, 2020, BMC Nephrology.

Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis.

W. Haley, R. Belostotsky, Y. Frishberg, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Comprehensive mutation screening in 55 probands with type 1 primary hyperoxaluria shows feasibility of a gene-based diagnosis.

D. Dawson, P. Lundquist, P. Harris, 2007, Journal of the American Society of Nephrology : JASN.

Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele.

S. Rossetti, D. Milliner, J. Olson, 2005, Kidney international.

Implications of Genotype and Enzyme Phenotype in Pyridoxine Response of Patients with Type I Primary Hyperoxaluria

D. Milliner, J. Olson, C. Monico, 2005, American Journal of Nephrology.

Combined liver‐kidney and kidney‐alone transplantation in primary hyperoxaluria

D. Milliner, C. Monico, 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria.

J. Lieske, P. Harris, K. Hopp, 2015, Journal of the American Society of Nephrology : JASN.

A safety and efficacy study of lumasiran, an investigational RNA interference (RNAi) therapeutic, in adult and pediatric patients with primary hyperoxaluria type 1

P. Haslett, J. Lieske, D. Magen, 2019, European Urology Supplements.

MP12-14 SAFETY AND EFFICACY STUDY OF LUMASIRAN, AN INVESTIGATIONAL RNA INTERFERENCE (RNAI) THERAPEUTIC, IN ADULT AND PEDIATRIC PATIENTS WITH PRIMARY HYPEROXALURIA TYPE 1 (PH1)

P. Haslett, J. Lieske, D. Magen, 2019, Journal of Urology.

Combined Liver–Kidney Transplantation for Primary Hyperoxaluria Type 2: A Case Report

J. Lieske, D. Milliner, T. Dhondup, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Plasma Oxalate as a Predictor of Kidney Function Decline in a Primary Hyperoxaluria Cohort

Lisa E. Vaughan, J. Lieske, D. Milliner, 2020, International journal of molecular sciences.

Inadvertent aluminum administration during plasma exchange due to aluminum contamination of albumin-replacement solutions.

D. Milliner, J. Coburn, J. Shinaberger, 1985, The New England journal of medicine.

An unusual renal complication in a patient with osteogenesis imperfecta.

B. Morgenstern, D. Milliner, L. Butani, 1995, American Journal of Kidney Diseases.

Silent Tyrosinemia Type I Without Elevated Tyrosine or Succinylacetone Associated with Liver Cirrhosis and Hepatocellular Carcinoma

Jennifer B. McCormick, S. Ekker, N. Giama, 2016, Human mutation.

Subspecialty Clinics: Nephrology Acute Interstitial Nephritis: Immunologie and Clinical Aspects

V. Torres, K. E. Holley, D. Milliner, 1988 .

Prevalence of low molecular weight proteinuria and Dent disease 1 CLCN5 mutations in proteinuric cohorts

J. Lieske, D. Goldfarb, P. Harris, 2019, Pediatric Nephrology.

Interpretation of serum aluminum values in dialysis patients.

W. J. Johnson, T. Moyer, D. Milliner, 1986, American journal of clinical pathology.

Pediatric renal-replacement therapy--coming of age.

D. Milliner, 2004, The New England journal of medicine.

Disseminated varicella infection in pediatric renal transplant recipients treated with mycophenolate mofetil.

B. Morgenstern, D. Milliner, W. S. Rothwell, 1999, Transplantation.

(L)‐2‐oxothiazolidine‐4‐carboxylate in the treatment of primary hyperoxaluria type 1

D. Assimos, D. Milliner, R. Holmes, 2001, BJU international.

Hydroxyproline Metabolism and Oxalate Synthesis in Primary Hyperoxaluria.

W. Lowther, D. Milliner, R. Holmes, 2018, Journal of the American Society of Nephrology : JASN.

Auxiliary Liver Transplant Is an Ineffective Treatment of Primary Hyperoxaluria

J. Trotter, D. Milliner, 2014, American Journal of Transplantation.

Clinical features of genetically confirmed patients with primary hyperoxaluria identified by clinical indication versus familial screening.

J. Lieske, D. Milliner, F. Enders, 2019, Kidney international.

Estimated GFR Slope Across CKD Stages in Primary Hyperoxaluria Type 1.

J. Lieske, P. Schulte, D. Milliner, 2022, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Quality: The Mayo Clinic Approach

James A. Dilling, S. Swensen, R. Zimmerman, 2009, American journal of medical quality : the official journal of the American College of Medical Quality.

Effect of a Novel Clinical Decision Support Tool on the Efficiency and Accuracy of Treatment Recommendations for Cholesterol Management

Hongfang Liu, Jane L. Shellum, Steve G. Peters, 2017, Applied Clinical Informatics.

Outcomes and complications of pregnancy in women with primary hyperoxaluria.

D. Milliner, S. Norby, 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Kidney Transplant Outcomes in Patients With Adenine Phosphoribosyltransferase Deficiency

B. Knebelmann, D. Milliner, R. Palsson, 2019, Transplantation.

Hand‐assisted laparoscopic donor nephrectomy for pediatric kidney allograft recipients

M. Stegall, G. Chow, B. Morgenstern, 2004, Pediatric transplantation.

Characterization of Stone Events in Patients With Type 3 Primary Hyperoxaluria

Lisa E. Vaughan, J. Lieske, P. Schulte, 2023, The Journal of urology.

Sustained Pyridoxine Response in Primary Hyperoxaluria Type 1 Recipients of Kidney Alone Transplant

J. Lieske, E. Bergstralh, D. Milliner, 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Early Subclinical Coronary Artery Calcification in Young Adults Who Were Pediatric Kidney Transplant Recipients

M. Stegall, L. Bielak, P. Peyser, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Natural History of Clinical, Laboratory, and Echocardiographic Parameters of a Primary Hyperoxaluria Cohort on Long Term Hemodialysis

P. Pellikka, J. Lieske, D. Milliner, 2021, Frontiers in Medicine.

Recovery From Dialysis in Patients With Primary Hyperoxaluria Type 1 Treated With Pyridoxine: A Report of 3 Cases.

J. Lieske, D. Milliner, J. Olson, 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Application of multivariate joint modeling of longitudinal biomarkers and time-to-event data to a rare kidney stone cohort

J. Lieske, P. Schulte, D. Milliner, 2022, Journal of Clinical and Translational Science.

Deferoxamine and coated charcoal hemoperfusion to remove aluminum in dialysis patients.

W. J. Johnson, D. Milliner, J. McCarthy, 1988, Kidney international.

Angiotensin converting enzyme inhibitors for reduction of proteinuria in children with steroid-resistant nephrotic syndrome

B. Morgenstern, D. Milliner, Dawn S. Milliner, 1991, Pediatric Nephrology.

Primary Hyperoxaluria Type 1

J. Lieske, P. Harris, D. Milliner, 1993 .